<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04278677</url>
  </required_header>
  <id_info>
    <org_study_id>2020 TJ 02</org_study_id>
    <nct_id>NCT04278677</nct_id>
  </id_info>
  <brief_title>Sleep Quality and Pain Medication Use Following Arthroscopic Rotator Cuff Repair</brief_title>
  <official_title>Sleep Quality and Pain Medication Use Following Arthroscopic Rotator Cuff Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate if oral melatonin reduces postoperative sleep 18
      disturbances and narcotics use. We will enroll patients undergoing primary arthroscopic
      rotator 19 cuff repair (ARCR) at the Rothman Institute.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This is a provider-crossover study design.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>This is a provider-crossover study design: subjects will receive treatment according to their provider's standard of care</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pittsburg Sleep Quality Index (PSQI)</measure>
    <time_frame>6 weeks post-surgery</time_frame>
    <description>PSQI is a validated outcome measure for sleep quality</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Sleep Disturbance</condition>
  <arm_group>
    <arm_group_label>Melatonin supplementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5mg melatonin tablets to be taken for 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No supplementation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>melatonin</intervention_name>
    <description>Melatonin capsules to be taken for 6 weeks</description>
    <arm_group_label>Melatonin supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who undergo primary ARCR

          -  Patient willing and able to complete postoperative surveys

        Exclusion Criteria:

          -  Daily melatonin use for &gt; 1 week during the last 3 months

          -  Irreparable tears

          -  Revision rotator cuff repairs

          -  Severe glenohumeral arthritis

          -  Concurrent adhesive capsulitis

          -  Age less than 18

          -  Pregnancy

          -  History of substance abuse (drug or alcohol)

          -  Workman's comp patient or patient has current litigation pending

          -  Allergy to melatonin

          -  History of delirium/psychiatric/depression/ on antidepressants

          -  History of insomnia/ on sleep aid medication

          -  Use of prescription sedatives

          -  use of Zelboraf (vemurafenib)

          -  Use of all blood thinning medications besides aspirin (warfarin, plavix, lovenox,
             etc.)

          -  Sleep apnea
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Orthopaedics at Egg Harbor Township</name>
      <address>
        <city>Egg Harbor Township</city>
        <state>New Jersey</state>
        <zip>08234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 18, 2020</study_first_submitted>
  <study_first_submitted_qc>February 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2020</study_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

